Sign in
CF

CAL-MAINE FOODS INC (CALM)·Q3 2020 Earnings Summary

Executive Summary

  • Returned to profitability despite soft pricing: net sales $345.6M (-10.0% y/y) and GAAP EPS $0.28 vs $0.82 y/y; up from Q2’s loss of $(0.21), driven by lower feed costs and stable volumes amid weak conventional pricing .
  • Mix/price: Specialty eggs were 35.0% of sales dollars (ex co-pack) with ASP $1.89/doz (-3.4% y/y); overall net ASP declined 10.0% y/y; dozens sold were flat (-0.2% y/y), underscoring pricing as the primary headwind .
  • Post-quarter setup positive: management said conventional market egg prices moved “significantly higher to record levels” after quarter-end, implying a Q4 tailwind; COVID-19-era demand and Easter seasonality were cited later in FY20 commentary .
  • Dividend withheld under variable policy due to cumulative losses of $61.9M through Q3; operations running normally with no supply chain disruptions reported at the time; company provided supplemental pay to employees amid COVID-19 .

What Went Well and What Went Wrong

  • What Went Well

    • Profitability inflected: operating income $5.2M and net income $13.7M in Q3 after Q2 loss, supported by farm production cost per dozen down 1.6% and feed costs down 3.6% y/y. Quote: “Our operations ran well… farm production costs per dozen were down 1.6%… feed costs [down] 3.6%” .
    • Supply backdrop improving: USDA hen numbers down to 330.0M (-11.8M y/y) and hatch rates down for three consecutive months through Feb-2020, a constructive sign for pricing. Quote: “Hen numbers… were 330.0 million… 11.8 million less… hatch rates decreased 4.95%… including 8.0% in February” .
    • Strategic investment continues: cumulative cage-free capex >$344M with expansions in FL/TX/UT to meet state mandates and customer demand. Quote: “We have invested over $344 million to expand our cage-free production… expansion projects underway in Florida, Texas and Utah” .
  • What Went Wrong

    • Pricing pressure: Southeast large conventional price -13.8% y/y; company net ASP -10.0% y/y, driving a 10.0% revenue decline despite flat volumes. Specialty dozens down 7.1% due to low conventional prices pressuring mix .
    • Specialty softness: specialty ASP -3.4% y/y to $1.89/doz; specialty dozens -7.1% y/y; specialty dollars still 35% but down from $131.1M to $117.7M .
    • Customer loss (prior quarter): in Q2, CALM lost a portion of non-specialty volumes to a major Southeast customer (4.6% of FY19 shell egg dozens; 6.1% of non-specialty dozens), raising utilization and mix risks while network is optimized; management is decommissioning older facilities to offset .

Financial Results

  • Income statement highlights and EPS versus prior periods
MetricQ3 2019Q1 2020Q2 2020Q3 2020
Net Sales ($M)$384.0 $241.2 $311.5 $345.6
GAAP EPS (Basic/Diluted)$0.82 / $0.82 $(0.94) / $(0.94) $(0.21) / $(0.21) $0.28 / $0.28
Net Income ($M)$39.8 $(45.8) $(10.1) $13.7
YoY Change Sales-10.0% (company reported)
QoQ Change Sales+29.1% vs Q1 (computed from reported figures) +10.9% vs Q2 (computed from reported figures)
  • Margins
MarginQ3 2019Q1 2020Q2 2020Q3 2020
Gross Margin %21.5% (82.441/383.992) -8.8% (-21.125/241.166) 9.4% (29.375/311.522) 14.4% (49.828/345.588)
EBIT Margin %9.9% (38.190/383.992) -26.3% (-63.470/241.166) -5.3% (-16.565/311.522) 1.5% (5.212/345.588)
Net Income Margin %10.4% (39.777/383.992) -19.0% (-45.760/241.166) -3.2% (-10.061/311.522) 4.0% (13.749/345.588)
  • Operating KPIs and pricing
KPIQ3 2019Q1 2020Q2 2020Q3 2020
Dozens Sold (000)271,805 254,424 261,026 271,278
Dozens Produced (000)222,213 214,298 231,467 239,072
Specialty Sales (% of dozens)24.7% 22.2% 22.3% 23.0%
Specialty Sales (% of dollars)35.0% 44.9% 36.0% 35.0%
Net Avg Selling Price ($/dozen)$1.373 $0.915 $1.160 $1.236
Specialty ASP ($/dozen, ex co-pack)$1.954 $1.863 $1.878 $1.887
Feed Cost ($/dozen)$0.421 $0.411 $0.416 $0.406
  • Estimates comparison
    • S&P Global consensus estimates were not retrievable due to a request limit at the time of query; therefore, we do not present “vs. consensus” deltas for Q3 2020. Values from S&P Global were unavailable.

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
Formal Financial GuidanceFY20/Q4None issuedNone issued; management highlighted significant post-quarter price increases and anticipated volatilityMaintained: no numeric guidance; directional commentary only
Dividend (Variable Policy)Q3 2020No dividend until cumulative profitability restoredNo dividend for Q3; cumulative losses to recover $61.9MMaintained policy; dividend withheld
Operations (COVID-19)Q4 FY20 onwardNot previously addressedFacilities operating normally; no supply chain/delivery disruptions; supplemental employee pay; strict protocolsNew disclosure; operational continuity emphasized
Cage-free ExpansionMulti-year>$314M invested; expansions in FL/TX/UT underway (Q2)>$344M invested; expansions in FL/TX/UT underway (Q3)Increased cumulative investment; projects progressing

Earnings Call Themes & Trends

Note: We did not locate a Q3 FY2020 earnings call transcript in our document set; themes reflect management commentary across quarterly press releases.

TopicQ1 FY20 (Aug 31, 2019)Q2 FY20 (Nov 30, 2019)Q3 FY20 (Feb 29, 2020)Trend
Supply/Demand Balance & PricingSevere conventional price decline; oversupply persists; hens 331.4M (+0.8M y/y) Conventional price -12.7% y/y; oversupply; lost a portion of non-specialty volumes to a SE customer Conventional price -13.8% y/y; post-quarter prices moved to record highs; hens 330.0M (-11.8M y/y) Improving into Q4 with price spike; structural supply tightening hinted
Specialty/Cage-Free StrategySpecialty revenue 44.9% of shell revenue; continuing cage-free capex Specialty dollars 36%; capex >$314M; expansions in FL/TX/UT Specialty dollars 35%; capex >$344M; expansions continue Steady execution; investment increased
Feed Costs & TariffsFeed per dozen flat; potential volatility from trade/tariffs Feed per dozen flat; volatility risk persists Farm cost/doz -1.6% y/y; feed -3.6% y/y; volatility risk remains Favorable in Q3; risks remain
Operations/COVID-19Operating normally; no disruptions; supplemental pay; protocols implemented New risk managed; continuity maintained
Customer/Channel DynamicsLost portion of non-specialty to major SE customer; optimizing network Specialty dozens down 7.1% on low conventional price gap Mix headwinds; optimization ongoing

Management Commentary

  • “Our results… reflect more challenging market conditions… However, we were pleased… to return to profitability for the quarter… While our sales volumes were in line with last year, our overall sales revenue was down due to the lower average selling prices…” .
  • “Since the end of the third quarter, market prices have moved significantly higher to record levels, and we expect to see continued price volatility through the end of our fiscal year.” .
  • “Our operations ran well during the third quarter… farm production costs per dozen were down 1.6 percent… feed costs [down] 3.6 percent…” .
  • “We have invested over $344 million to expand our cage-free production… expansion projects underway in Florida, Texas and Utah…” .
  • COVID-19: “Facilities are operating normally… we have not experienced any supply chain or delivery disruptions… we are providing supplemental pay to all of our employees…” .

Q&A Highlights

  • No Q&A highlights are available from our document set; we did not locate a Q3 FY2020 earnings call transcript or related Q&A materials in the filings or press releases reviewed (8-K and Exhibit 99.1) .

Estimates Context

  • We attempted to retrieve S&P Global (Capital IQ) consensus for Q3 FY2020 (EPS and revenue) but could not due to a platform request limit at the time of query; as a result, we do not present “vs. consensus” variances for this quarter. We did not substitute third-party estimates to maintain consistency with the stated methodology. S&P Global consensus data was unavailable at query time.

Key Takeaways for Investors

  • Pricing is the swing factor: Q3 profitability returned despite weak conventional prices; management flagged record post-quarter price levels, creating a positive near-term setup into Q4 amid COVID-driven at-home demand and Easter seasonality .
  • Mix sensitivity persists: specialty dozens fell 7.1% on low conventional pricing, pressuring specialty mix; watch relative price spreads for mix recovery as conventional prices normalize higher .
  • Cost discipline supports downside: farm production costs/doz down 1.6% and feed down 3.6% y/y provided cushion; continued vigilance needed given tariff/COVID-related volatility risk to grain inputs .
  • Capacity and compliance positioning: >$344M invested in cage-free capacity with ongoing projects (FL/TX/UT) aligns with state mandates and retailer commitments; positions CALM for secular specialty growth .
  • Dividend on hold under policy: no Q3 dividend and $61.9M cumulative losses to recover; a sustained return to profitability would be prerequisite to resume payouts, making Q4 trajectory critical .
  • Customer/channel optimization: prior loss of non-specialty volumes in Q2 highlights concentration risk; management is decommissioning older facilities and integrating acquisitions to optimize footprint .